Astellas to work with Adaptimmune to develop 'off the shelf'...

Astellas is to work with UK biotech Adaptimmune Therapeutics to develop allogeneic ‘off-the-shelf’ T-cell therapies for cancer.

AI specialist Exscientia signs drug discovery tie-up with Ba...

Experts call for review of innovative cancer therapies to bo...

There should be an independent review of how advances in cancer treatment are valued and paid for by the NHS and healthcare providers, according to a new policy report calling for improveme

Blueprint gets first approval as FDA backs stomach cancer dr...

US biotech Blueprint Medicines has its first approved drug, after the FDA backed its oncology drug Ayvakit for a certain kind of stomach cancer.

China’s Adagene raises $69m for cancer immunotherapies

Almirall strikes option deal to buy Bioniz and dermatology d...

Almirall has begun an option agreement with California’s Bioniz, which could see it buy the entire company and its skin cancer and alopecia drug BNZ-1.